Inactive Instrument

XPED Share Price Australian S.E.

Advanced Medical Equipment & Technology

End-of-day quote Australian S.E.
- ^AUD	-

08-24	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
02-11	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI

Oakridge International Limited is an Australia-based Internet of things (IoT) and healthcare technology company. The Company is primarily engaged in the business of selling professional healthcare technology equipment and solutions to healthcare facilities. The Companyâ€™s segments include Healthcare technology, Technology development and Geothermal projects. The Technology development segment is focused on the IoT technology. The Healthcare technology segment operates through its wholly owned subsidiary, JCT Healthcare Pty Ltd (JCT), which is a provider of technology solutions for the healthcare sector. JCT develops and distributes its own range of nurse call hardware and software solutions for use across multiple healthcare sectors including hospitals, aged care, disability care and supported independent living. The Geothermal projects segment includes Sokoria Geothermal Project, Ngebel Geothermal Project, Dairi Prima Geothermal Project and Puga Geothermal Project.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Rankings

Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!

SEIZE THE OFFER!

Market Cap	2.05M 1.46M 1.27M 1.2M 1.09M 2.04M 139M 14.3M 5.53M 70.89M 5.47M 5.35M 227M	P/E 2025	-13.4x	P/E 2026	21.1x
Enterprise Value	1.51M 1.07M 933K 883K 802K 1.5M 103M 10.51M 4.07M 52.12M 4.02M 3.93M 167M	EV / Sales 2025	0.6x	EV / Sales 2026	0.41x
Free-Float	18.74%	Yield 2025 *	-	Yield 2026	-

08-24	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2026	CI
02-11	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2025	CI
22/08/25	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2025	CI
03/03/25	Oakridge International Limited Announces Board Changes	CI
19/02/25	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2024	CI
29/08/24	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2024	CI
15/04/24	Oakridge International Enters AU$500,000 Shares and Option Subscription Agreement	MT
06/03/24	Oakridge International Gets Nearly AU$180,000 R&D Tax Rebate	MT
28/02/24	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2023	CI
21/08/23	Oakridge International Limited Reports Earnings Results for the Full Year Ended June 30, 2023	CI
29/03/23	Oakridge International Limited Announces Change of Principal Place of Business	CI
17/02/23	Oakridge International Shrinks Fiscal H1 Loss by 61%	MT
17/02/23	Oakridge International Limited Reports Earnings Results for the Half Year Ended December 31, 2022	CI

21/12/21	Oakridge International : Unmarketable Parcel Sale Facility	PU
02/06/17	XPED Ltd Company Update	AW
01/06/17	XPED Ltd Receives 20 Million Unit Order for iPark	AW
22/05/17	XPED Ltd Complete Jemsoft Acquisition	AW
19/05/17	XPED Ltd Lenze App Delivered	AW

Manager	Title	Age	Since
Con Unerkov CEO	Chief Executive Officer	57	02/02/2021
Julie Edwards SEC	Corporate Secretary	-	-

Director	Title	Age	Since
Con Unerkov CHM	Chairman	57	30/12/2019
Peter Whelan BRD	Director/Board Member	-	28/01/2021
Wally Pastuch BRD	Director/Board Member	-	02/03/2025

XPED Share Price Australian S.E.

Stocks

Advanced Medical Equipment & Technology

Valuation: XPED

Latest news: XPED

Press Releases: XPED

Managers and Directors: XPED

Medical Software & Technology Services

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
VEEVA SYSTEMS INC.	+0.23%	+1.70%	-3.34%	+27.49%	42.89B
PRO MEDICUS LIMITED	+2.37%	+1.63%	-43.77%	+130.73%	12.32B
SECTRA AB	+2.38%	+5.09%	-2.90%	+112.25%	5.8B
HEARTFLOW, INC.	+2.36%	+8.35%	+55.20%	-	4.2B
GENERATE BIOMEDICINES, INC.	+5.87%	+8.09%	-	-	2.01B
OMNICELL, INC.	+0.63%	+0.98%	+4.44%	-39.53%	1.48B
XUNFEI HEALTHCARE TECHNOLOGY CO., LTD.	-0.60%	-3.93%	-39.62%	-	1.02B
ARBUTUS BIOPHARMA CORPORATION	+0.30%	-1.07%	+14.33%	+154.52%	999M
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD.	-3.37%	-4.97%	+32.16%	+44.38%	908M
Average	+1.12%	-0.13%	+2.06%	+71.64%	7.96B
Weighted average by Cap.	+1.01%	+1.16%	-6.57%	+55.54%

	2025	2026
Net sales	2.43M 1.73M 1.51M 1.43M 1.3M 2.42M 166M 16.99M 6.57M 84.23M 6.5M 6.36M 270M	3.45M 2.45M 2.13M 2.02M 1.84M 3.43M 235M 24.06M 9.3M 119M 9.21M 9M 382M
Net income	-129K -91.6K -79.78K -75.51K -68.6K -128K -8.77M -899K -348K -4.46M -344K -336K -14.27M	109K 77.64K 67.63K 64K 58.15K 109K 7.44M 762K 295K 3.78M 292K 285K 12.1M
Net Debt	-267K -190K -165K -157K -142K -266K -18.19M -1.86M -721K -9.24M -713K -697K -29.59M	-542K -386K -336K -318K -289K -540K -36.93M -3.79M -1.46M -18.77M -1.45M -1.42M -60.08M